Special report of the Board of Directors on the self-examination of the independence of independent directors

Sichuan Baili Tianheng Pharmaceutical Co., Ltd.

In accordance with the requirements of the "Measures for the Administration of Independent Directors of Listed Companies", the Shanghai Stock Exchange Science and Technology Innovation Board Stock Listing Rules and the "Shanghai Stock Exchange Science and Technology Innovation Board Self-Regulatory Guidelines No. 1 for Companies Listed on the Science and Technology Innovation Board - Standardized Operations" and other requirements, the board of directors of Sichuan Bailey Tianheng Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") evaluated the independence of the company's independent directors Mr. Li Mingyuan, Mr. Xiao Geng and Mr. Dai Zewei and issued the following special opinions:

After verifying the employment experience of Mr. Li Mingyuan, Mr. Xiao Geng, and Mr. Dai Zewei, the company's independent directors, and the relevant self-examination documents signed by the company, the company's board of directors confirmed that the above-mentioned persons do not hold any position in the company other than independent directors, nor do they hold any position in the company's major shareholder company. There is no interest relationship between the company's independent directors and the company and major shareholders or other relationships that may hinder their independent and objective judgment, and there are no other circumstances that affect the independence of the independent directors. The company's independent directors have always maintained a high degree of independence during the reporting period. Their performance of duties complied with the relevant requirements for the independence of independent directors in the "Administrative Measures for Independent Directors of Listed Companies" and "Self-Regulatory Guidelines for Companies Listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange No. 1 - Standardized Operations" and other regulations. They effectively performed their duties as independent directors in terms of internal control, standardized operations and the protection of the rights and interests of small and medium-sized investors, and provided fair and independent professional opinions for the company's decision-making.

Board of Directors of Sichuan Baili Tianheng Pharmaceutical Co., Ltd.

April 27, 2026